Notizia - Recent Pharma, Healthcare and Biotech Happenings

MedTech News and Updates for Penumbra, Axonics, Stimwave, SonoScape

Penumbra’s Indigo System; Axonics’s F15 Recharge-free SNS; Stimwave’s FREEDOM-1 Clinical Trial; Virtual Incision’s MIRA Platform; SonoScape’s HD-550 Endoscopy system; SMART Medical’s G-EYE Colonoscope Series

Penumbra launched the Indigo® System with Lightning™ 7 and Lightning 12 Intelligent Aspiration in Europe On April 14, 2022, Penumbra, Inc., a leading medical device company focused on developing innovative therapies for neuro and vascular conditions, received the CE mark for its Indigo Aspiration System with Lightning 7 and Lightning 12 and also made it commercially available in Europe. The Indigo System with Lightning is an intelligent aspiration system powered by Penumbra ENGINE and comprises a dual pressure sensor for real-time blood flow monitoring, which is an advanced and unique computer-aided clot detecting technology that can differentiate b...

Explore More...

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Penumbra’s Indigo System; Axonics’s F15 Recharge-free SNS; Stimwave’s FREEDOM-1 Clinical Trial; Virtual Incision’s MIRA Platform; SonoScape’s HD-550 Endoscopy system; SMART Medical’s G-EYE Colonoscope Series

Incyte meets endpoint in second atopic dermatitis trial; NeoTX lands USD 45 M series C; Five Prime Therapeutics’ pancreatic cancer a bust

J&J collaborates with BARDA; Virus kills pancreatic cancer cells; ALX raises USD 105 million for CD47 drug

Good news for Kite’s KTE-X19, and Aquestive’s Libervant; and a commercialization deal between ReForm Biologics, MilliporeSigma

Immune cells for age-related diseases; Regeneron’s antibody for 2019-nCoV; FDA nods for hydrogel injection

First-ever Peanut allergy treatment; Dinutuximab misses primary endpoint; Insmed’s shares Soares

Annovis announces IPO results; Conatus merges with Histogen; Novartis discontinues its generic journey

Acceleron Pharma’s drug sotatercept touches the phase 2 mark; GT Medical receives nod for GammaTile; New treatment strategy for Parkinson’s disease

Tepezza receives approval; a new way to treat Alzheimer’s

More Views & Analysis

Imfinzi combo gets ODD; Mayzent gets EU nod; Positive results of VP-102

Thumbs down to NKTR-181, Lilly expands its insulin armamentarium

Eli Lilly to acquire Dermira, Boehringer buys Enleofen’s IL-11 platform, Biogen acquires Pfizer’s Alzheimer’s drug

Novome raises USD 33M, Buyout of Bioniz, Adagene raises USD 69M

Nunaps raises USD 4.2M; Arcutis files for USD 100M IPO

Roche, Sarepta collaborates; FDA approval for Merck’s Ervebo, and Allergan’s Ubrelvy

GBT, Syros; Takeda, Cevance collaborates; IND application to ZN-c3

Wave Life Sciences stocks implode; Amarin’s VASCEPA approval; GSK seeks approval

Subscribe to our Updates

Daily

Weekly

Monthly